The detection of HER-2 amplification is very crucial for the prognosis and treatment of BC; the amplification of the HER-2 gene suggests that BC patients have a high degree of malignancy and poor prognosis, which is suitable for targeted therapy [39]. Here, ERBB2 is linked to breast cancer.